Monthly Archives: September 2021

Rivers, lakes and wetlands cover just 1% of the Earths surface but are home to nearly 10% of all species, including fish, mammals, birds, insects and crustaceans. But these rich, diverse ecosystems are in free fall. Worldwide, species are declining faster now than at any other time in human history, and fresh waters are losing more species than land or ocean ecosystems.

Today about 1 in 4 freshwater creatures face extinction. Wetlands are disappearing three times faster than forests. Across the globe, water quality is plummeting, polluted by plastic, sewage, mining sludge, industrial and agricultural chemicals and much more.

Its challenging to study how these stresses are affecting aquatic life. There are many diverse threats, and river networks cover broad geographic regions. Often they run through remote, nearly inaccessible areas. Current techniques for monitoring freshwater species are labor-intensive and costly.

In our work as researchers in ecology, we are testing a new method that can vastly expand biomonitoring: using environmental DNA, or eDNA, in rivers to catalog and count species. Federal and local agencies need this data to restore water quality and save dwindling species from extinction.

With traditional biomonitoring methods, scientists count individual species and their abundance at just a few sites. For example, one recent study of mountaintop mining impacts on fish in West Virginia sampled just four sites with a team of four researchers.

Collecting and identifying aquatic organisms requires highly skilled ecologists and taxonomists with expertise in a wide variety of freshwater species. For each sample of fish or invertebrates collected in the field, it takes from hours to weeks to identify all of the species. Only wealthy nations can afford this costly process.

Conserving threatened and endangered species and keeping river ecosystems healthy requires monitoring broad areas over time. Sensitive aquatic insects and fish species are the freshwater equivalent of the proverbial canary in a coal mine: If these species are absent, thats a strong indicator of water quality problems. The cause may be mining, agriculture, urbanization or other sources, as well as dams that block animals downstream movements.

Innovations in genetic technology have created a powerful, affordable new tool that we are now testing. The process involves extracting eDNA from genetic material floating in the water skin, scales, feces and single-celled organisms, such as bacteria.

By analyzing this genetic information, we can detect a wide range of species. We started considering using eDNA for our research in 2018, after several studies demonstrated its power to monitor single species of interest or groups of organisms in rivers and oceans.

Collecting eDNA is easy: One 4-ounce water sample can capture remnant DNA from thousands of aquatic species. Another benefit is that it doesnt require killing wildlife for identification.

In the lab, we analyze the DNA from different taxonomic groups one by one: bacteria, algae, fish and macroinvertebrates organisms that lack backbones and are large enough to see, such as snails, worms and beetles. Many researchers study just one group, but we assess all of them at the same time.

We then match our DNA sequences with freshwater species that are already catalogued in existing databases. In this way, we can chart the distribution and abundance of these organisms within and across rivers.

This process requires just a cheap filter, a syringe and vials, and anyone can do it. Commercial eDNA companies charge less than $200 to extract and sequence a sample.

Using this method, we extensively surveyed 93 rivers in West Virginia looking at the entire tree of life, from the tiniest bacteria to fish in two days with a four-person team.

The Appalachian rivers that we study teem with life. These are some of the worlds most biologically diverse temperate freshwater ecosystems, home to many fish species, as well as salamanders, crayfish, mussels and aquatic insects. Many are found nowhere else. We tallied more than 10,000 different species in those 93 waterways.

The area where we worked is an intensive coal mining region, which heavily affects waterways. Liquids draining from mines are acidic, but in this region they react with limestone rock, so the net effect is to make local streams alkaline. Mine drainage also increases streams salinity and concentrations of sulfate and other contaminants. Our research revealed that mined watersheds held 40% fewer species than areas without mining operations, and the organisms we detected were less abundant than in unaffected rivers.

We believe this new approach represents a revolution for biomonitoring, expanding our ability to quantify and study freshwater life. Its also an important new conservation tool, allowing scientists to track changes in populations of endangered or invasive species. Researchers also can use eDNA to monitor biodiversity or discover new species in oceans or soils.

This open-science method makes all DNA data widely available, with nearly all sequences placed in public repositories. Moving forward, we expect that it will aid many types of research, as well as state and local monitoring and conservation programs. Investments in collecting eDNA and identifying organisms and analyzing their genetic signatures will continue to make it a more effective tool.

[Over 100,000 readers rely on The Conversations newsletter to understand the world. Sign up today.]

Efforts are underway to better target various individual species, focusing on those that are endangered, invasives that damage ecosystems and sensitive species that serve as indicators of river health. Scientists are freezing eDNA samples at -112 degrees F (-80 C) in expectation that technological advances may yield more information in the future.

Traditional monitoring approaches remain valuable, but eDNA adds an important new tool to the toolkit. Together, these approaches can begin to answer many questions about food webs, the conservation status of species, reproduction rates, species interactions, organisms health, disease and more.

The rest is here:
Scientists at work: We use environmental DNA to monitor how human activities affect life in rivers and streams - The Conversation US

After almost 45 years to the day that police found her body dumped near a cemetery, Baltimore County Police said Wednesday detectives identified a girl known as Woodlawn Jane Doe thanks to new DNA testing.

The young woman who turned out to be 16 years old when she was killed was identified by police as Margaret Fetterolf from Alexandria, Virginia. Family members told detectives that the teen went missing in 1975, one year before she was found strangled, with her body wrapped in a white sheet and her hands bound behind her back near Lorraine Park Cemetery.

In a video provided by county police, Cpl. Dona L. Carter, who works with the criminal investigations unit, said this is significant development in the case that could help catch the people involved in the murder.

This is a really big break in the case, she said in the video. Because without knowing who she is or where she came from, we really dont have too much to go on. We need to know who she may have been with to get some leads for this case.

Carter said the department plans to head to Alexandria to try to drum up any leads in the area, including talking with and visiting the Hayfield Secondary School, where Fetterolf attended at the time she went missing. Detectives are also interested in talking with any friends or former classmates.

For years police believed Fetterolf hailed from the Boston area after testing pollen particles that clung to her clothing in 2016. Authorities said the blend of cedar and mountain hemlock pollen, identified by a scientist with U.S. Customs and Border Patrol, was a combination only found at the Arnold Arboretum in Boston or the New York Botanical Garden.

Clues found at the scene had long pointed to Massachusetts. The type of cloth seed bag pulled over Fetterolfs head was sold only in Massachusetts. A key in her pocket was made by ILCO in Fitchburg, Massachusetts. A crude tattoo of the letters JP could signify the Boston neighborhood of Jamaica Plain.

Police said Wednesday its unclear when or if Fetterolf was ever in Boston.

It was only recently Virginia became an area of interest, police spokeswoman Joy Stewart said.

One year after the pollen discovery, the National Center for Missing and Exploited Children released a new facial reconstruction image of Fetterolf.

Then, police say their big break came earlier this year.

The National Center for Missing and Exploited Children which has assisted county police with the investigation along with Bode Technology, one of the largest private forensic DNA laboratories in the United States, more DNA testing was done. Those results were crucial in helping identify Fetterolf, authorities said.

A woman on her way to church on Sept. 12, 1976, spotted a van near the Lorraine Park Cemetery. Officers found Fetterolf wearing beige jeans, a white short-sleeved shirt and a rawhide necklace. Police previously thought she was in her late teens or 20s. she was about 5-foot-8, weighed 159 pounds, and had brown hair and brown eyes. Tips initially poured in but waned as the years passed.

At about 5-foot-8 and 159 pounds, the brown eyed and brown haired girl was also believed to have been sexually assaulted. The drug chlorpromazine, an anti-psychotic medication, was found in her system.

Anyone who might have information in this case is asked to contact Baltimore County detectives at 410-307-2020.

See more here:
Slain teen known for 45 years as Woodlawn Jane Doe identified by DNA testing - MassLive.com

The new report on the DNA Polymerase Market provides estimations of the size of the global market and share and size of key regional markets during the historical period of20192029. The study provides projections of the opportunities and shares, both vis--vis value and volume, of various segments in the DNA Polymerase Market during the forecast period of 2019 2029. The business intelligence study offers readers a granular assessment of key growth dynamics, promising avenues, and the competitive landscape of the DNA Polymerase Market.2019is considered as the baseyear and 2029 as the estimation year.

Request For Brochure -https://www.factmr.com/connectus/sample?flag=B&rep_id=4707

While there will be uncertainties, stakeholders can navigate them by factoring in historic and current drivers of change when strategizing for 2020 and beyond. Among these drivers are a growing and aging population, rising prevalence of chronic diseases, infrastructure investments, technological advancements, evolving care models, higher labor costs amidst workforce shortages, and the expansion of health care systems in developing markets. Health care systems need to work toward a future in which the collective focus shifts away from treatment, to prevention and early intervention.

For years, financial challenges have shadowed the worlds public and private health systems to varying degrees, and we expect the situation to persist in 2020. This will make value a watchword in health care payment reform. The entry of non-traditional players in the health care sector have the potential to both support and suppress incumbents efforts to grow revenue. Digital giants and digital-first health solution disruptors are demonstrating that there could be an easier and more user-friendly way to conduct health care transactions.

To offer a comprehensive assessment of opportunities, the study makes a scrutiny of growth prospects in various regions. The key regions comprise the following geographical segments:

North America (U.S., Canada)

Latin America ( Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)

Europe (Germany, Italy, UK, Spain, France, Russia, Belgium, Netherlands, Luxemburg, Norway, Denmark, Iceland, Sweden, Poland, Ukraine, Czech Rep, Rest of Europe)

Asia Pacific Excluding Japan (India, Australia & New Zealand, Greater China, S. Korea, ASEAN Countries, Rest of APEJ)

Japan

CIS & Russia

Middle East and Africa (GCC, Turkey, Iran, Israel, South Africa, Rest Of MEA)

The detailed assessments focus on, inter alia, on the regulatory and macroeconomic frameworks, prevailing pricing structure, imminent investment pockets, and emerging application areas. Taking the analysis further, the study helps readers get a better understanding of the trends characteristics of the emerging markets, including government regulations crucial to growth of such markets. Shares of major regional markets are also presented in the analysis.

The study provides detailed profile of key players and their offering in the DNA Polymerase Market which include

ThermoFisher Scientific

Bio-Rad Laboratories

MerckKGaA,

Jena Bioscience GmbH

Agilent Technologies

New EnglandBiolabs

The report offers insight into the competitive dynamic in the DNA Polymerase Market which has shaped the major strategies of each player. It also covers recent moves such as partnerships and collaborations, mergers and acquisitions, diversification and research investments, of each prominent player. The key factors that shape the entry barrier and intensity of competition in the DNA Polymerase Market are presented in the analysis. Further, the study provides PESTLE analyses of numerous players and an evaluation of how the competitive landscape will evolve over the forecast period.

Tentatively, the global high-fidelity DNA polymerase market can be segmented on the basis of the application type, end user and geography.

Based on the application, the global high-fidelity DNA polymerase market is segmented as:

DNA Cloning

SNP Analysis

Next Generation Sequencing Applications

Other Applications

Based on the end user, the global High-fidelity DNA polymerase market is segmented as:

Research Centers

Academic Institutions

Biotechnology Centers

Others

Request For Customized Research here -https://www.factmr.com/connectus/sample?flag=RC&rep_id=4707

The global DNA Polymerase Market report answers numerous pertinent questions, some of which are:

What are some of the latent areas of investments in the DNA Polymerase Market?

Which region is expected to emerge as showing the most attractive growth rate during the forecast period and which factors will be crucial to its growth?

What trends are likely to change the status quo of the positions held by leading players of the DNA Polymerase Market in the not-so-distant future?

Which product/service/technology segments holds game-changing potential to dramatically shape the competitive dynamic in the DNA Polymerase Market?

What are the strategies adopted by top players to retain their stronghold in the DNA Polymerase Market?

Which strategic moves will new entrants adopt to gain a strong foothold in the DNA Polymerase Market?

How can Fact.MR Make Difference?

1. In-depth understanding of key industry trends shaping the present growth dynamics

2. Offers value chain analysis and price trend analysis of various offering of competitors

3. Offers data-drive decision to help companies decide strategies that need recalibration

4. Offers insights into areas in research and development that should attract

Identifies data outliers before your competitors

Explore Fact. MRs Coverage on theHealthcareDomain:

Cell-Free Fetal DNA Testing MarketAccording to the latest research by Fact.MR, theCell Free Fetal DNA Testing Marketis set to witness exponential growth during 2021-2031. Increasing adoption of advance testing methodwilllead to upsurgegrowth outlook forCell- Free Fetal DNA Testingin the long run.

Home DNA Testing MarketAccording to the latest research by Fact MR, theHome DNA testing Marketis set to witness steady growth during 2021-2031. Demand for the market will witness a steady recovery in the short term, with an optimistic growth outlook in the long run.

Organ Care MarketAccording to the latest research by Fact MR, Organ Care Market is set to witness steady growth during 2021-2031. Demand for the market will witness a steady recovery in the short-term, with an optimistic growth outlook in the long run.

About Us:

Fact.MR Market research and consulting agency with a difference! Thats why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and well be an able research partner.Contact:US Sales Office:

11140 Rockville PikeSuite 400Rockville, MD 20852United StatesTel: +1 (628) 251-1583Corporate Headquarter:Unit No: AU-01-H Gold Tower (AU),Plot No: JLT-PH1-I3A,Jumeirah Lakes Towers,Dubai, United Arab EmiratesEmail:sales@factmr.comVisit Our Website:https://www.factmr.com

Read this article:
Introduction of New Research Equipment In The European Healthcare Industry, High-Fidelity DNA Polymerase Holds Maximum Revenue Share - BioSpace

The Gadgeteer is supported by readers like you! If you buy something through links on our site, we may earn an affiliate commission. Thank you! Learn more.

REVIEW Aches and pains, we all have them or will have them at some point in our lives. Whether these pains come as a result of epic workouts or from arthritis and other chronic medical conditions, finding a way to alleviate inflammation and pain without drugs can be a struggle. Thats where the DNA Vibe Jazz Band Vibe is supposed to help. No, it isnt a musical instrument, its a light therapy device. Lets take a look.

The DNA Vibe Jazz Band is a therapy device that has been designed to reduce pain, enhance performance, and allow for faster recovery of aching joints and muscles using red and near infrared light, magnets, and micro vibration. It can be used on ankles, knees, elbows, wrists, shoulders, necks, backs, and more.

Power output 2 Watts (Optimized for minimum output)Power density 6 mW/cm^2Red light 650 nm 675 nm 10 emitters, the exact wavelength is proprietaryNear-infrared 825 nm 850 nm, 18 emitters, the exact wavelength is proprietaryMagnetic 45-55 micro Tesla, 1 emitter, 6-10 Hz pulsed (intensity is comparable to earths naturally occurring magnetic field)Micro-vibration 225 Hz, Controllable on/off, pulse pattern & periodicity selectableDimensions 5 x 11.25

The DNA Vibe Jazz Band Vibe is an oval-shaped device that is housed in a neoprene cover. The Vibe has a short power cable with a magnetic connector attached to it. The connector reminds me of an Apple MagSafe cable that we used to have on MacBooks. It provides a quick connect and disconnect of the power adapter cable which plugs into your wall. That means that youll always be tethered when youre using this device. If you want to use the Vibe wirelessly, you can check out the Cordless Power Pack.

If you flip the band over, youll see that theres a mesh cover.

The Jazz Band Vibe feels like a thick slab of solid gel. But when you plug it in, 10 large LED glow red and the Vibe vibrates with short bursts.

To control the DNA Vibe Jazz Band Vibe Light Therapy Device, youll need to download the DNA Vibe app for your phone. I did all my testing with my iPhone 12 Pro Max. Bluetooth pairing of the Vibe with my phone was quick and simple and the app itself is also just as simple to use.

The app has one main screen (shown above) that lets you set a timer for the therapy session and adjust the red light, near infrared light, magnetics, and toggle the micro vibration feature. It is suggested that you use the device twice a day for 20-30 minutes to achieve results. What kind of results? According to DNA Vibe, you should see:

Basically, you just wrap the Vibe around the body part that needs therapy and use one of the straps to keep it in place. That sounds easy but it can be a bit awkward when youre trying to place the Vibe around your own hand, arm, elbow, or shoulder. You should also know that the body part needs to be bare and the Vibe needs to be positioned against the area that needs help.

I tested the DNA Vibe Jazz Band Vibe Light Therapy device with my elbow and my hand. Once in a while, Ill give myself a mild case of tendonitis from leaning on my elbow too much while Im sitting at my desk. I had noticed lately that my elbow is achy so I used the Vibe to see if it could relieve the inflammation and mild pain. I was very much surprised when one 30 minute session with the Vibe made the pain go away. I considered that a fluke and decided to give the Vibe something difficult to fix my hand. My right hand has the beginning of arthritis or some type of inflammation problem in the thumb near the wrist. So used the Vibe as suggested, 20-30 minutes once a day for 2 weeks. Here are before pictures comparing my left hand and my right hand so you can better see how the right hand is slightly swollen.

Original post:
DNA Vibe Jazz Band Vibe review - Light therapy device - The Gadgeteer

While its unsurprisingly common for in-laws to fret over their sons new partner, some just dont know when to stop the phrase no one is good enough for your son comes to mind.

For one Redditor, his parents committed a stunning form of betrayal after they pulled a Maury-style DNA test on their grandson to confirm the baby was, in fact, his.

Subsequently, the man and his wife of two years cut his parents out of their lives, and he has now turned to Reddit for much-needed reassurance that he did not overreact by doing so.

The man explained how he had met his wife, Sonya, in a restaurant where she worked as a waitress. Instantly, his parents disapproved as they believed she was using [him] to achieve her American dream. Naturally, the man was offended by their assumption and slammed his parents for being racist.

Circumstances worsened after the pair were due to wed when he turned to his parents for their blessing to which they declined. Because of this, we decided to elope and only invited my brother and Sonyas best friends to be our witnesses, he wrote.

Two years on, the happy couple welcomed their first child, Garreth, which prompted the parents to reach out in hopes of being a part of their grandsons life. Mykindhearted wife didnt think twice to welcome my parents into our lives, the Reddit user said. She let themmeet our baby two days after being dischargedfrom the hospital.

Sign up to our free Indy100 weekly newsletter, The Viral Democracy

The relationship between the foursome appeared to be heading in a progressive direction that was until the Reddit user overheard his mom say to his son, Arent you the cutest baby ever? I am so glad to confirm you are indeed my grandson.

After a back and forth between the pair, his mom finally caved and told him the truth. They had baby Garreth DNA tested to make sure that he was their biological relation.

The man turned to Reddit for much-needed reassurance

I wasspeechlessfor a moment, and before Iblew up from anger, he wrote, I tolddad to give me my son and they better leave before I lose whatever respect I had left for them.

My mom was veryapologeticand said its because theydont trust my wife and that our son looks nothing like me.

It wasnt until two weeks later when the Redditor finally told his wife about the incident after she was questioning why his parents hadnt been visiting. She started crying and it broke my heart, he said, especially after she attempted to win their approval.

The pair collectively decided to no longer let his parents into the childs life. When mom called to ask when they can visit again, I told them they are no longer welcome in our sons life.Mom called my dad and I told him the same thing, he said.

He waslivid, he called me ungrateful and cruel.

He also said afew choice words about my wife which angered me more. I didnt even hear the rest because I just hung up.

Fellow Reddit users flocked to the thread to jump to the mans defence.

This right here, I dont even know why its up for debate. One wrote. Literally a no brainer. Like who they f**k are they to go behind your back and do that and still have the fkn audacity to bad mouth OPs wife. Im so mad and I dont even know these people!

Another sent out a clear message to those saying he shouldnt deprive the child of a relationship with his grandparents. They are openly racist towards his wife/ the mother of this child. They will make remarks about that, they will make him feel bad about his heritage and will talk badly about his mother even when he is there. Don't let them into your life, stay your ground.

Read more:
Man cuts parents out of his life after they secretly DNA tested his new baby - indy100

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

PRESS RELEASE

Immunocore presents data at the European Society for Medical Oncology (ESMO) Congress 2021 demonstrating a reduction in circulating tumor DNA (ctDNA) while on tebentafusp is associated with overall survival in the Phase 2 clinical trial

Linear correlation between the magnitude of ctDNA reduction on tebentafusp and improved overall survival

70% of evaluable patients had any ctDNA reduction and 14% had ctDNA clearance

Immunocore Holdings Plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, presented new data from the Companys lead program, tebentafusp (IMCgp100), at an oral presentation at the European Society for Medical Oncology (ESMO) Congress.

The findings presented by Alexander N. Shoushtari MD, medical oncologist at Memorial Sloan Kettering Cancer Center, demonstrated that reduction by Week 9 in circulating tumor DNA (ctDNA) while on tebentafusp is strongly associated with overall survival (OS). A majority (70%) of evaluable patients had any ctDNA reduction while 5% of patients had radiographic response per the RECISTv1.1 criteria. In addition, 14% of patients had complete ctDNA clearance and long OS; this included some patients with best response of stable or progressive disease. The analysis was based on the phase 2 trial of tebentafusp in HLA-A*02:01 positive, previously treated patients with metastatic uveal melanoma (mUM) (IMCgp100-102).

Uveal melanoma is characterized by a defined set of unique mutations that can be measured in the blood as free circulating tumor DNA, said David Berman, Immunocores Head of Research and Development, We found that the degree of ctDNA reduction from tebentafusp was strikingly correlated with overall survival. This association was observed even in patients whose tumor lesions appeared radiographically stable or progressing and suggests that clinical benefit from tebentafusp may occur even in patients who did not have a RECIST response.

The U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the United Kingdoms Medicines and Healthcare Products Regulatory Agency (MHRA) have each accepted applications seeking the approval of tebentafusp for the treatment of HLA-A*02:01-positive adult patients with metastatic uveal melanoma based on the primary endpoint of overall survival (OS) from the Phase 3 study IMCgp100-202.

See more here:
Immunocore (IMCR) presents data at ESMO demonstrating reduction in circulating tumor DNA while on tebentafusp is associated with OS in the Phase 2...